Novel artemisinin derivative with anti-angiogenic activity that inhibits growth and migration of cancer cells via VEGFR2 signaling
We are very happy that our BIOFLOATTM 96-well plates supported the work of Xiaohua Lu, Sebastian Blatt, Mona Dawood, Sabine M. Klauck, Edmond Fleischer , Peer W. Kammerer and Thomas Efferth. They generated cell spheroids from our BIOFLOAT 96 well plates which shows that a novel ARS-type compound exerts potent anticancer effects in vitro and in vivo. View the research paper by clicking here :
96 WELL PLATES
The BIOFLOAT™ 96-well plate provides a highly defined, fully inert, and cell-repelling surface.